Cargando…
MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
BACKGROUND: There have been conflicting reports regarding the function of miR-20a in a variety of cancer types and we previously found it to be dysregulated in sporadic versus familial papillary thyroid cancer. In this study, we studied the expression of miR-20a in normal, benign and malignant thyro...
Autores principales: | Xiong, Yin, Zhang, Lisa, Kebebew, Electron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032243/ https://www.ncbi.nlm.nih.gov/pubmed/24858712 http://dx.doi.org/10.1371/journal.pone.0096103 |
Ejemplares similares
-
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2015) -
Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2016) -
MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer
por: Xiong, Yin, et al.
Publicado: (2011) -
Genistein up-regulates miR-20a to disrupt spermatogenesis via targeting Limk1
por: Gu, Hao, et al.
Publicado: (2017) -
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis
por: Sadowski, Samira M., et al.
Publicado: (2015)